Yahoo Finance

MyOme and Ms.Medicine Announce Strategic Partnership to Redefine Personalized Primary Care Through Genomics

MENLO PARK, Calif. and CINCINNATI, Dec. 3, 2025 /PRNewswire/ -- MyOme, a leading clinical whole-genome testing and polygenic risk modelling (PRS) company, today announced a strategic partnership with ...
newswise

Illumina and MyOme Strike Collaboration Deal Including Strategic Investment to Support MyOme's Clinical Trial That Could Save U.S. Healthcare $200 Billion Annually

Newswise — SAN DIEGO and MENLO PARK, Calif., Dec. 11, 2025 -- Illumina, Inc. (NASDAQ: ILMN) and MyOme, a leading genomics innovation and risk modeling company, today announced a collaboration and ...
PR Newswire

MyOme and Oracle Collaborate to Advance Genomic Risk Prediction at Global Scale

MyOme, Inc., a leader in clinical whole-genome analysis and polygenic risk modeling, today announced that its predictive genomic ...
Opinion
NatureOpinion

Genetic testing articles from across Nature Portfolio

Genetic testing involves the detection of specific alleles, mutations, genotypes or karyotypes that are associated with heritable traits, diseases or predispositions to disease for the individual or ...